Tdspharm티디에스팜
464280 · KOSDAQ · ₩464280 · 티디에스팜
₩4,685▼ ₩85 (1.78%)End-of-day · Oct 27, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | |
|---|---|---|
| Revenue | ₩28B | ₩28B |
| Cost of sales | ₩20B | ₩20B |
| Gross profit | ₩7.5B | ₩7.7B |
| Operating income | ₩3.8B | ₩3.7B |
| Net income | ₩4.3B | ₩3.7B |
| Net income to shareholders | ₩4.3B | ₩3.7B |
Balance sheet
| 2025 | 2024 | |
|---|---|---|
| Total assets | ₩54B | ₩49B |
| Current assets | ₩30B | ₩40B |
| Cash and equivalents | ₩1.2B | ₩4.7B |
| Total liabilities | ₩11B | ₩11B |
| Current liabilities | ₩11B | ₩11B |
| Borrowings | ₩0 | ₩775M |
| Total equity | ₩43B | ₩39B |
| Shareholders' equity | ₩43B | ₩39B |
Cash flow
| 2025 | 2024 | |
|---|---|---|
| Cash from operations | ₩3.8B | ₩3.9B |
| Free cash flow | ₩3.8B | ₩3.9B |
Consolidated where available. Amounts in won.
Also known as: Tdspharm / 티디에스팜 / 464280 / KRX:464280
Source: KRX statistical information